JPS572710B2 - - Google Patents

Info

Publication number
JPS572710B2
JPS572710B2 JP9045273A JP9045273A JPS572710B2 JP S572710 B2 JPS572710 B2 JP S572710B2 JP 9045273 A JP9045273 A JP 9045273A JP 9045273 A JP9045273 A JP 9045273A JP S572710 B2 JPS572710 B2 JP S572710B2
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP9045273A
Other languages
Japanese (ja)
Other versions
JPS5046675A (en:Method
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS5046675A publication Critical patent/JPS5046675A/ja
Publication of JPS572710B2 publication Critical patent/JPS572710B2/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/36—Compounds containing oxirane rings with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
JP9045273A 1972-08-11 1973-08-11 Expired JPS572710B2 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3755072A GB1382526A (en) 1972-08-11 1972-08-11 Morpholine derivatives

Publications (2)

Publication Number Publication Date
JPS5046675A JPS5046675A (en:Method) 1975-04-25
JPS572710B2 true JPS572710B2 (en:Method) 1982-01-18

Family

ID=10397311

Family Applications (2)

Application Number Title Priority Date Filing Date
JP48090453A Pending JPS49124079A (en:Method) 1972-08-11 1973-08-11
JP9045273A Expired JPS572710B2 (en:Method) 1972-08-11 1973-08-11

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP48090453A Pending JPS49124079A (en:Method) 1972-08-11 1973-08-11

Country Status (22)

Country Link
US (2) US3974158A (en:Method)
JP (2) JPS49124079A (en:Method)
AT (8) AT327929B (en:Method)
AU (2) AU471402B2 (en:Method)
BE (2) BE803283A (en:Method)
CH (4) CH594646A5 (en:Method)
CS (4) CS182798B2 (en:Method)
DD (2) DD108299A5 (en:Method)
DE (2) DE2340874A1 (en:Method)
DK (1) DK135505B (en:Method)
ES (1) ES417796A1 (en:Method)
FR (2) FR2195448B1 (en:Method)
GB (1) GB1382526A (en:Method)
HU (2) HU166870B (en:Method)
IE (1) IE37928B1 (en:Method)
IL (2) IL42842A0 (en:Method)
IN (1) IN137769B (en:Method)
NL (2) NL7311069A (en:Method)
PL (4) PL90322B1 (en:Method)
SE (1) SE385889B (en:Method)
SU (7) SU537627A3 (en:Method)
ZA (2) ZA735007B (en:Method)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1064927A (en) * 1975-01-29 1979-10-23 Yuji Kawashima Process of producing 2-(indenyloxymethyl) morpholine derivatives
IL56369A (en) * 1978-01-20 1984-05-31 Erba Farmitalia Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them
EP0227338A1 (en) * 1985-12-19 1987-07-01 Imperial Chemical Industries Plc Sulfur-containing heterocyclic compounds, their production and their use as pesticides
GB8827152D0 (en) * 1988-11-21 1988-12-29 Wellcome Found Anti-atherosclerotic diaryl compounds
US5290814A (en) * 1988-11-21 1994-03-01 Burroughs Wellcome Co. Anti-atherosclerotic diaryl compounds
EP0507488A1 (en) * 1991-03-27 1992-10-07 Merck & Co. Inc. Inhibitors of HIV-1 reverse transcriptase
AU3364493A (en) * 1992-01-28 1993-09-01 Smithkline Beecham Plc Compounds as calcium channel antagonists
DE69732359T2 (de) 1996-08-23 2005-06-23 Neurosearch A/S Disubstituierte morpholin-, oxazepin- oder thiazepinderivate, deren herstellung und verwendung als dopamin-d4-rezeptorantagonisten
EP1187810A2 (en) * 1999-05-25 2002-03-20 Sepracor, Inc. Heterocyclic analgesic compounds and their use
US6677332B1 (en) 1999-05-25 2004-01-13 Sepracor, Inc. Heterocyclic analgesic compounds and methods of use thereof
US7361666B2 (en) 1999-05-25 2008-04-22 Sepracor, Inc. Heterocyclic analgesic compounds and methods of use thereof
US6645980B1 (en) 2000-05-25 2003-11-11 Sepracor Inc. Heterocyclic analgesic compounds and methods of use thereof
US6635661B2 (en) 2000-05-25 2003-10-21 Sepracor Inc. Heterocyclic analgesic compounds and methods of use thereof
US7294637B2 (en) 2000-09-11 2007-11-13 Sepracor, Inc. Method of treating addiction or dependence using a ligand for a monamine receptor or transporter
EP1318988A2 (en) 2000-09-11 2003-06-18 Sepracor, Inc. Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission)
TW200602299A (en) * 2004-06-24 2006-01-16 Sankyo Co Saturated n-calbonyl heterocyclic compounds, their preparation and the synthetic mediates
TWI452044B (zh) * 2007-06-15 2014-09-11 Mitsubishi Tanabe Pharma Corp 嗎啉衍生物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH386443A (de) * 1959-12-16 1965-01-15 Geigy Ag J R Verfahren zur Herstellung von neuen tetrasubstituierten Alkylendiaminen
GB1138405A (en) * 1966-12-28 1969-01-01 Ici Ltd Morpholine derivatives

Also Published As

Publication number Publication date
US3974156A (en) 1976-08-10
CS182799B2 (en) 1978-05-31
ATA974974A (de) 1975-05-15
FR2195454B1 (en:Method) 1977-02-25
IE37928L (en) 1974-02-11
AT327210B (de) 1976-01-26
IN137769B (en:Method) 1975-09-13
CS182798B2 (en) 1978-05-31
AT327929B (de) 1976-02-25
NL7311069A (en:Method) 1974-02-13
BE803284A (fr) 1974-02-06
ATA975074A (de) 1975-05-15
DK135505B (da) 1977-05-09
AU5848573A (en) 1975-01-30
JPS5046675A (en:Method) 1975-04-25
SU521844A3 (ru) 1976-07-15
ES417796A1 (es) 1976-02-16
PL90322B1 (en:Method) 1977-01-31
FR2195448B1 (en:Method) 1977-02-25
HU166870B (en:Method) 1975-06-28
AT326675B (de) 1975-12-29
ATA924974A (de) 1975-03-15
AU468101B2 (en) 1975-12-18
ATA701673A (de) 1975-06-15
DE2340873A1 (de) 1974-02-28
FR2195454A1 (en:Method) 1974-03-08
CS183681B2 (en) 1978-07-31
ATA974874A (de) 1975-05-15
GB1382526A (en) 1975-02-05
JPS49124079A (en:Method) 1974-11-27
CH594642A5 (en:Method) 1978-01-13
PL91728B1 (en:Method) 1977-03-31
AT328460B (de) 1976-03-25
DD108299A5 (en:Method) 1974-09-12
CH594645A5 (en:Method) 1978-01-13
NL7311068A (en:Method) 1974-02-13
CS182790B2 (en) 1978-05-31
SU503521A3 (ru) 1976-02-15
CH594644A5 (en:Method) 1978-01-13
AU471402B2 (en) 1976-04-29
SU508200A3 (ru) 1976-03-25
IE37928B1 (en) 1977-11-09
DD107931A5 (en:Method) 1974-08-20
SU537627A3 (ru) 1976-11-30
ZA735007B (en) 1974-06-26
PL91729B1 (en:Method) 1977-03-31
DE2340874A1 (de) 1974-02-21
HU167000B (en:Method) 1975-07-28
AT327930B (de) 1976-02-25
AT327932B (de) 1976-02-25
SE385889B (sv) 1976-07-26
BE803283A (fr) 1974-02-06
IL42841A0 (en) 1973-10-25
FR2195448A1 (en:Method) 1974-03-08
US3974158A (en) 1976-08-10
ZA735008B (en) 1974-06-26
PL95166B1 (en:Method) 1977-09-30
ATA701773A (de) 1975-05-15
SU509231A3 (ru) 1976-03-30
DK135505C (en:Method) 1977-10-17
SU508199A3 (ru) 1976-03-25
CH594646A5 (en:Method) 1978-01-13
ATA925074A (de) 1975-04-15
SU508201A3 (ru) 1976-03-25
AU5849173A (en) 1975-01-30
AT327931B (de) 1976-02-25
IL42842A0 (en) 1973-10-25
IL42841A (en) 1976-04-30

Similar Documents

Publication Publication Date Title
DK135505C (en:Method)
JPS5125339B2 (en:Method)
JPS4928335A (en:Method)
JPS5318564B2 (en:Method)
JPS547237B2 (en:Method)
JPS4928077A (en:Method)
FR2172801A1 (en:Method)
JPS4978817A (en:Method)
JPS496193U (en:Method)
RO58854A2 (en:Method)
JPS4974415U (en:Method)
JPS495115U (en:Method)
JPS4944455U (en:Method)
CH572093A5 (en:Method)
CH561494A5 (en:Method)
CH570302A5 (en:Method)
CH569913A5 (en:Method)
CH568940A5 (en:Method)
CH568890A5 (en:Method)
CH568438B5 (en:Method)
CH567875A5 (en:Method)
CH577932A5 (en:Method)
CH567390A5 (en:Method)
CH574728A5 (en:Method)
CH566589A5 (en:Method)